INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ acute myocardial infarction, heart failure,        │ acute myocardial infarction, heart failure,        │     100 │
│ neoplastic disease, chronic diseases that may      │ neoplastic disease, chronic diseases that may      │         │
│ affect the inflammatory profile both systemic and  │ affect the inflammatory profile both systemic and  │         │
│ epicardial (cancer, chronic intestinal             │ epicardial (cancer, chronic intestinal             │         │
│ inflammation, hepatitis, AIDS); life expectancy \< │ inflammation, hepatitis, AIDS); life expectancy <  │         │
│ 6 months, previous CABG and/or other open heart    │ 6 months, previous CABG and/or other open heart    │         │
│ surgery intervention, acute coronary syndrome      │ surgery intervention, acute coronary syndrome      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ patients aged \>18, \<75, left ventricle ejection  │ patients aged >18, <75, left ventricle ejection    │      99 │
│ fraction (LVEF) \>50%, multivessel coronary        │ fraction (LVEF) >50%, multivessel coronary disease │         │
│ disease detected by coronarography, indication to  │ detected by coronarography, indication to receive  │         │
│ receive a CABG, stable CAD. All diabetics and non  │ a CABG, stable CAD. All diabetics and non          │         │
│ diabetics                                          │ diabetics                                          │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 75 Years │ patients aged >18, <75, left ventricle ejection    │      17 │
│                                   │ fraction (LVEF) >50%, multivessel coronary disease │         │
│                                   │ detected by coronarography, indication to receive  │         │
│                                   │ a CABG, stable CAD. All diabetics and non          │         │
│                                   │ diabetics                                          │         │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 18 Years │ patients aged >18, <75, left ventricle ejection    │      18 │
│                                   │ fraction (LVEF) >50%, multivessel coronary disease │         │
│                                   │ detected by coronarography, indication to receive  │         │
│                                   │ a CABG, stable CAD. All diabetics and non          │         │
│                                   │ diabetics                                          │         │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 94
Average Levenshtein Ratio of individual lines: 58.5
OverAll Ratio: 76.25
